These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7985487)

  • 1. Marked but transitory elevation of hepatic transaminases after subcutaneous calcium heparin administration.
    Tison T; Dazzi F; Vianello F; Radossi P; Girolami A
    Acta Haematol; 1994; 92(1):54. PubMed ID: 7985487
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
    Maroto-Iitani M; Higaki Y; Kawashima M
    Contact Dermatitis; 2005 Apr; 52(4):228-30. PubMed ID: 15859998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hematoma of the abdominal wall and subcutaneous calcium heparin].
    Miralles Basseda C; Rosell Gratacos A; Gelonch Romeu J; Camps Ausas I; Monreal Bosch M; Oller Sales B
    Rev Clin Esp; 1991 Feb; 188(2):109-10. PubMed ID: 1828298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall].
    Lemke H; Imhoff M; Löhlein D
    Chirurg; 1994 Aug; 65(8):714-6. PubMed ID: 7956538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin induced thrombocytopaenia secondary to intraperitoneal heparin exposure.
    Kaplan GG; Manns B; McLaughlin K
    Nephrol Dial Transplant; 2005 Nov; 20(11):2561-2. PubMed ID: 16014345
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin-Induced Skin Necrosis Occurring at a Distance From Injection Sites.
    Estébanez A; Silva E; Cordero P; Martín JM
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):869-871. PubMed ID: 31151665
    [No Abstract]   [Full Text] [Related]  

  • 7. A cautious look at heparin.
    Lilley LL; Guanci R
    Am J Nurs; 1995 Sep; 95(9):14-6. PubMed ID: 7573213
    [No Abstract]   [Full Text] [Related]  

  • 8. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and tolerance of heparin-calcium at low doses in postinfarct ischemic cardiopathy].
    Melina D; Guerrera G; Melina G; Guerrera C
    Clin Ter; 1992 Dec; 141(12):447-56. PubMed ID: 1493666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
    Zanon C; Bortolini M; Chiappino I
    Tumori; 2005; 91(6):477-80. PubMed ID: 16457145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcified subcutaneous nodule in a heart transplant recipient.
    Taylor A; Parry G
    Clin Exp Dermatol; 1996 Mar; 21(2):173-4. PubMed ID: 8759216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram].
    Porta A; Magni S; Camagna P; Donati M; Dinelli CA
    Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692
    [No Abstract]   [Full Text] [Related]  

  • 13. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.
    Cook D; Meade M; Guyatt G; Walter SD; Heels-Ansdell D; Geerts W; Warkentin TE; Cooper DJ; Zytaruk N; Vallance S; Berwanger O; Rocha M; Qushmaq I; Crowther M
    J Crit Care; 2011 Apr; 26(2):223.e1-9. PubMed ID: 21482348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum aminotransferases after low-dose heparin treatment. Short communication.
    Olsson R; Korsan-Bengtsen BM; Korsan-Bengtsen K; Lennartsson J; Waldenström J
    Acta Med Scand; 1978; 204(3):229-30. PubMed ID: 696422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels].
    Själander A; Johansson L; Hillarp A; Bergqvist D; Tengborn L; Svensson P
    Lakartidningen; 2009 Mar 4-10; 106(10):682-5. PubMed ID: 19418688
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy.
    Kim J; Smith KJ; Toner C; Skelton H
    Int J Dermatol; 2004 Apr; 43(4):252-60. PubMed ID: 15090006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study.
    Muñoz-Venturelli P; Wang X; Lavados PM; Stapf C; Robinson T; Lindley R; Heeley E; Delcourt C; Chalmers J; Anderson CS;
    Int J Stroke; 2016 Jul; 11(5):549-56. PubMed ID: 27009893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducible elevation of liver transaminases by topical 8-methoxypsoralen.
    Park YM; Kim TY; Kim HO; Kim CW
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):261-3. PubMed ID: 7727284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Subcutaneous heparin is as good as low-molecular-weight heparin in the acute treatment of thrombo-embolic disease.
    Munro A; English C
    Emerg Med J; 2008 May; 25(5):287-9. PubMed ID: 18434466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.